Viewing Study NCT00982150


Ignite Creation Date: 2025-12-24 @ 5:13 PM
Ignite Modification Date: 2026-01-10 @ 4:47 AM
Study NCT ID: NCT00982150
Status: TERMINATED
Last Update Posted: 2013-08-26
First Post: 2009-09-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Extension Study of Talampanel for Amyotrophic Lateral Sclerosis (ALS)
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module